Drug intelligence / Profile preview

tribulus terrestris saponins

Development stage
Phase 4
Modality
Small Molecules
Administration
Oral
01

Overview

Tribulus terrestris saponins are a group of steroidal saponin compounds extracted from the plant Tribulus terrestris. These compounds are considered the primary bioactive constituents responsible for many of the purported pharmacological effects attributed to Tribulus terrestris extracts. Saponins from this plant have been studied for their anti-inflammatory, antioxidant, antihypertensive, and potential anticancer properties. Mechanistically, they have been shown to modulate inflammatory cytokine expression (such as TNF-α and IL-6), inhibit nitric oxide production in immune cells stimulated by lipopolysaccharides, induce apoptosis in cancer cell lines via caspase activation and ERK pathway modulation, inhibit nuclear factor kappa B (NF-κB) signaling pathways, and exhibit ACE-inhibitory activity that may contribute to blood pressure reduction. In animal models and some human studies, these saponins also demonstrate protective effects against oxidative stress and may influence hormone levels through hypothalamic-pituitary-adrenal axis modulation[2][5][4]. However, clinical evidence supporting efficacy for most indications is limited or inconclusive.

Brand names
Xinnaoshutong
Other names
tribulus terrestris extractTT saponinstotal saponins of Tribulus terrestrisTST
02

Targets

ACE (Angiotensin Converting Enzyme)CASP3 (Caspase-3)CASP8 (Caspase-8)MAPK3 (Mitogen-activated protein kinase 1)IL-6 (Interleukin 6)NFKB1 (NF-κB1)OCT2 (Organic cation transporter 2)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on tribulus terrestris saponins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tribulus terrestris saponins.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call